Natixis’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $261K | Buy |
|
|||||
|
2025
Q1 | $95.7K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $5.55K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $3.52M | Sell |
|
|||||
|
2023
Q4 | $27.7M | Sell |
|
|||||
|
2023
Q3 | $44.1M | Buy |
|
|||||
|
2023
Q2 | $5.37M | Sell |
|
|||||
|
2023
Q1 | $6.92M | Sell |
|
|||||
|
2022
Q4 | $7.38M | Sell |
|
|||||
|
2022
Q3 | $18.5M | Sell |
|
|||||
|
2022
Q2 | $18.5M | Sell |
|
|||||
|
2022
Q1 | $65M | Sell |
|
|||||
|
2021
Q4 | $78.2M | Sell |
|
|||||
|
2021
Q3 | $99.9M | Buy |
|
|||||
|
2021
Q2 | $101M | Buy |
|
|||||
|
2021
Q1 | $87.2M | Sell |
|
|||||
|
2020
Q4 | $125M | Buy |
|
|||||
|
2020
Q3 | $47.4M | Buy |
|
|||||
|
2020
Q2 | $28.3M | Sell |
|
|||||
|
2020
Q1 | $30.1M | Sell |
|
|||||
|
2019
Q4 | $32.8M | Sell |
|
|||||
|
2019
Q3 | $38.3M | Buy |
|
|||||
|
2019
Q2 | $48.7M | Sell |
|
|||||
|
2019
Q1 | $59M | Buy |
|
|||||
|
2018
Q4 | $45.9M | Buy |
|
|||||
|
2018
Q3 | $50.2M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $1.11M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $5.03M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $224K | Buy |
|